Skip to content

A prospective cohort study of the effect of insomnia on progression of MCI to AD

A prospective cohort study of the effect of insomnia on progression of MCI to AD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081471
Enrollment
Unknown
Registered
2024-03-01
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment

Interventions

Exposed group (With insomnia disorder):None
Non-exposed group (Without insomnia disorder):None

Sponsors

Beijing Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Provide written informed consent; ? Age =55 years old; (3) The chief complaint of memory impairment, provided by the patient himself, his family or an insider; (4) Memory impairment was not consistent with age and education level (clinical memory scale score was lower than 1.5 SD of age and education level matching norm); (5) Normal daily living ability, that is, daily living ability Rating Scale (ADL) =100 points; ? Hachinski Ischemia Index scale score < 4; ? Education level above primary school; The course of MCI is =3 years.

Exclusion criteria

Exclusion criteria: Previous or current DSM-5 diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, Alzheimer's disease, other causes of secondary dementia and other psychiatric disorders; Have other serious physical diseases such as cardiovascular, liver, kidney, respiratory system, endocrine system, nervous system or blood system diseases; ? severe aphasia, visual and hearing impairment, etc., can not complete the scale assessment; A history of alcohol dependence and other psychoactive substance abuse (e.g. antipsychotics, benzodiazepines).

Design outcomes

Primary

MeasureTime frame
Conversion rate of MCI to AD at study end point (3 years);;

Secondary

MeasureTime frame
The change values of cognitive scores from baseline at different visiting points: MMSE, MoCA, ADL, AVLT, SDMT, VFT, BNT, HAMD-17, HAMA;Change in neuroimaging measures from baseline: bilateral hippocampal volume, total gray and white matter volume, white matter hypersignal;Changes of sleep indicators from baseline: PSQI, Epworth sleepiness Scale, sleep duration, PSG parameters (sleep duration, sleep quality, etc.), neuroelectrophysiological indicators;

Countries

China

Contacts

Public ContactQinge Zhang

Beijing Anding Hospital

zqe81@126.com+86 138 1159 1959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026